Are COX-2 inhibitors safe in congestive heart failure?

被引：0

|

作者：

Jassal, DS ^{[1
]}

Howlett, J ^{[1
]}

Cox, JL ^{[1
]}

机构：

[1] Dalhousie Univ, Halifax, NS, Canada

来源：

CIRCULATION | 2003年 / 108卷 / 17期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3023

引用

收藏

页码：665 / 665

页数：1

相关论文

共 50 条

[41] Defining COX-2 inhibitors
Lipsky, PE
JOURNAL OF RHEUMATOLOGY, 2000, 27 : 13 - 16
[42] COX-2 inhibitors and ligaments
Mitka, M
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24): : 3071 - 3071
[43] COX-2 inhibitors and the kidney
Perazella, MA
HOSPITAL PRACTICE, 2001, 36 (03): : 43 - +
[44] COX-2 inhibitors - Preface
Brooks, PM
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (17) : U2 - U4
[45] COX-2 inhibitors and hypertension
Weder, Alan B.
Zhang, J.
Ding, E. L.
Song, Y.
CURRENT HYPERTENSION REPORTS, 2007, 9 (01) : 3 - 4
[46] COX-1 and COX-2 inhibitors
Hawkey, CJ
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (05) : 801 - 820
[47] COX-2 inhibitors linked to early free vascular flap failure
Reactions Weekly, 2006, 1114 (1) : 3 - 3
[48] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
Debabrata Mukherjee
Eric J Topol
Arthritis Res Ther, 5
[49] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
Luo, C
He, ML
Bohlin, L
ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
[50] COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors
Whittle, BJR
GUT, 2000, 47 (03) : 320 - 325

← 1 2 3 4 5 →